Advanced Cell Diagnostics (ACD), a Bio-Techne brand

ACD - a Bio-Techne brand

ACD - a Bio-Techne brand, is a pioneer and leader in the advancement of spatial genomics by unlocking the power of RNA and developing cell- and tissue-based research.

Based on proprietary technology, ACD’s RNAscope Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform enables detection and quantification of RNA in situ at single molecule sensitivity.

Features

Strong detection of low expressors- Visualization of even very low expressing genes in any of the three probe channels.
Compatible with multiple sample types- Detection of signals at low exposure and supports of FFPE samples and fresh frozen samples.
Supports dual ISH and IHC protocols- High and stable signals enable sequential detection of proteins by IHC on the same samples.
Sharper, crisper signal- Strong balanced signals across all three channels make it easy to generate publication-quality data.

Benefits

Easy to use - no need to match expression level of targets with channel sensitivity
Novel multiplex nucleic acid ISH technology with a patented probe design
Delivers clear and actionable results with high sensitivity and specificity

Automated Protocol - Best-in-class RNA ISH for your automated system of choice

For labs that require high throughput and automated RNA in situ hybridization (ISH) analysis, ACD has partnered with Leica Biosystems to deliver RNAscope™ ISH automated assays.

Common applications include studies to map co-expression of targets within the same cellular context (e.g. secreted ligand and its receptor) or to profile gene expression in a specific cell type expressing a known marker (e.g. a specific stem cell marker).

Custom Protocol

Using proprietary ACD RNAscope™ Probe Design Pipeline, we provide double "Z" oligo probes designed to hybridize to your specific RNA target of interest. We can design in situ hybridization RNA probes for virtually ANY gene in ANY genome for visualization in ANY tissue or cell.

RNAscope™ 2.5 LS Reagent Kit – BROWN

RNAscope™ 2.5 LS Reagent Kit – RED

RNAscope™ 2.5 LS Duplex Assay

RNAscope™ LS Multiplex Fluorescent Assay

BaseScope™ LS Reagent Kit – RED

miRNAscope™ LS Reagent Kit Red

Brad Dirks

Director, Global Partnerships & Strategic Alliances

Brad Dirks leads the Spatial Biology Division’s efforts to build and maintain strong relationships with our external partners to deliver “best-in-class” assays to researchers around the world.

Rhonda Henshall-Powell

Ph.D., Marketing Manager

Rhonda’s experience in Digital Product and Social Media Marketing, and Strategic Key Opinion Leader relationships drives global sales and marketing teams to bring new products and raise brand awareness in the Spatial Biology Markets.

A novel in situ hybridization technology for the detection of small regulatory RNAs with spatial and morphological context

Download Now

Semiquantitative Methods for GFP Immunohistochemistry and in situ Hybridization to Evaluate AAV Transduction of Mouse Retinal Cells Following Subretinal Injection

Publication Year:	2021
Country:	USA
Publication:	Bondarenko G, Sorden SD, Christian BJ, Webster S, Sharma AK. Semiquantitative Methods for GFP Immunohistochemistry and In Situ Hybridization to Evaluate AAV Transduction of Mouse Retinal Cells Following Subretinal Injection. Toxicol Pathol. 2021;49(3):537-543. doi:10.1177/0192623320964804
Institute:	Covance Laboratories Inc
Instrument:	BOND RX, RNAscope ISH assay, RNAscope 2.5 LS Reagent Kit—RED
Authors:	Bondarenko G, Sorden SD, Christian BJ, Webster S, Sharma AK.
Study Goals:	To develop methods for the evaluation of green fluorescent protein (GFP) and GFP transcript biodistribution in paraformaldehyde-fixed paraffin-embedded (PFPE) eye sections to assess the effectiveness of Adeno-associated virus (AAV) gene delivery in an experimental ocular toxicity study
Keywords:	adeno-associated virus vector, green fluorescent protein, immunohistochemistry, in situ hybridization, ocular toxicology, retina, gene therapy

Detection of Engineered T Cells in FFPE Tissue by Multiplex in situ Hybridization and Immunohistochemistry

Publication Year:	2021
Country:	USA
Publication:	Wright JH, Huang LY, Weaver S, et al. Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistry. J Immunol Methods. 2021;492:112955. doi:10.1016/j.jim.2020.112955
Institute:	Fred Hutchinson Cancer Research Center 4Department of Immunology, University of Washington School of Medicine
Instrument:	BOND RX, Leica Dewax Solution, Epitope Retrieval Solution 2 , BOND Polymer Refine DAB Detection, (ACD) Enzyme (Proteinase III), ACD target probe, WPRE, positive control probes for mouse, human peptidyl-prolyl cis-trans isomerase B (PPIB; ACD #322100), negative control probe 4-hydroxy-tetrahydrodipicolinate reductase (DapB; ACD #312038), RNAscope 2.5 LS Reagent Kit-Brown
Authors:	Wright JH, Huang LY, Weaver S, et al.
Study Goals:	To develop a method for characterizing engineered T cells in fixed tissue using in situ hybridization (ISH) to the woodchuck hepatitis post-transcriptional regulatory element (WPRE)
Keywords:	CAR-T, TCR-T, in situ hybridization, Immunohistochemistry, WPRE, Immunophenotyping

For Research Use Only. Not for use in diagnostic procedures.